pemetrexed,cisplatin,gemcitabine,pembrolizumab
merck
['keynote,671', 'nsclc', 'pembro', 'sclc', 'keynote-671']
1 exciting news from #asco23! the keynote-671 study investigated pembrolizumab with platinum-based chemotherapy for early-stage nsclc. this promising combination could be a game-changer in cancer treatment. 
🫁Pneumo-Onco🩺 Chef de Pôle de Méd à Orientation Onco 🏥 @CHToulonLaSeyne 🔬Conseil Scientifique @IFCTLung / Pdte du 3C VarOuest 👉🏼#HopitalPublic #LungCancer